アレルギーと神経ペプチド　Vol.6　2010年

出版社： 日本医学館
著者：
発行日： 2010-02-24
分野： 臨床医学：内科  >  アレルギー
ISBN： 9784890447015
電子書籍版： 2010-02-24
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

1,100 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

550 円(税込)

購入する

商品紹介

第6回アレルギーと神経ペプチド編集会議での内容をもとに、“精神的ストレスと喘息”という経験的にはよく知られているが、科学の光を当てにくい分野について紹介。その他の基礎・臨床に関する論考なども収録。

目次

  • アレルギーと神経ペプチド　Vol.6　2010年

    ―目次―

    特集　“ストレスと気道アレルギー”

    PRESENTATION
    　ストレス喘息とμオピオイド受容体

    COMMENT & IMPRESSION
    “ストレス喘息とμオピオイド受容体”を聞いて
    　ストレスと免疫応答に関しては過去多くの興味深い研究がある
    　上気道とストレス
    　喘息発作とストレス
    　気管支喘息の憎悪におけるストレスの関与
    　ストレス、皮膚アレルギー、そしてステロイド
    　中枢神経系および末梢神経系におけるμオピオイド受容体の作用

    REVIEW＆TOPICS　
    　喘息気道リモデリングのCT画像による評価　
    　神経ペプチドneuromedin Uとneuromedin S　
    　COX-2とvasoactive intestinal peptide(VIP)　
    　オロパタジンによるヒスタミン非依存性の痒みの制御の可能性

    EDUCATIONAL LECTURE
    　TRPチャネルを介した温度受容の分子機構

    WAVE OF MEDICINE
    　“ニューロペプタイド研究会のあゆみ”第17回研究会報告

    DRUG-REPORT
    　TRPM8チャネルと皮膚感覚

    文献紹介
    　１．乾癬の増悪における神経系因子の変化(EI-Nour H et al.)　
    　２．通年性鼻アレルギー患者鼻粘膜における神経増殖因子の局在
    　　　　(Bresciani M et al.)　
    　３．新規CB2受容体刺激薬(GW833972A)のモルモットとヒトの
    　　　　気道における知覚神経機能の阻害活性(Belvisi MG et al.)

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

特集に寄せて

P.2 掲載の参考文献
1) 日本アレルギー学会(西間三馨・監):アレルギー疾患 診断・治療ガイドライン 2007, 協和企画, 東京, 2007.
 
2) Holgate ST:The airway epithelium is central to the pathogenesis of asthma. Allergol Int 57:1-10, 2008.
 

特集 "ストレスと気道アレルギー"

P.10 掲載の参考文献
1) Giron Caro F et al.:Melatonin and beta-endorphin changes in children sensitized to olive and grass pollen after treantment with specific immunotherapy. Int Arch Allergy Immunol 126:91-96, 2001.
 
P.12 掲載の参考文献
1) Chapman KE, Seckl JR:11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys) function. Neurochem Res 33(4):624-636, 2008.
PubMed
2) Katayama I, Bae SJ, Hamasaki Y, Igawa K, Miyazaki Y, Yokozeki H, Nishioka K:Stress response, tachykinin, and cuta-neous inflammation. J Investig Dermatol Symp Proc 6 (1):81-86, 2001.
 
3) Tominaga M, Ogawa H, Takamori K:Possible roles of epidermal opioid sys-tems in pruritus of atopic dermatitis. J Invest Dermatol 127 (9):2228-2235, 2007.
 
4) Kodama A, Horikawa T, Suzuki T, Ajiki W, Takashima T, Harada S, Ichihashi M:Effect of stress on atopic dermatitis:investigation in patients after the great hanshin earthquake. J Allergy Clin Immunol 104 (1):173-176, 1999.
PubMed
P.13 掲載の参考文献
1) Kiecolt-Glas er JK, Heffner KL, Glaser R et al.:How stress and anxiety can alter immediate and late phase skin test responses in allergic rhinitis. Psychoneuroendocrinology 34:670-680, 2009.
 
2) Nishioka K, Okano M, Ichihara Y et al.:Immunosuppressive effect of re-straint stress on the initiation of allergic rhinitis in mice. Int Arch Allergy Immu-nol 136:142-147, 2005.
 
3) Vayisoglu Y, Ozcan C, Pekdemir H et al.:Autonomic nervous system evalua-tion using heart rate variability parame-ters in vasomotor rhinitis patients. J Oto-laryllgol 35:338-342, 2006.
 
4) Jaradeh SS, Smith TL, Torrico L et al.:Autonomic nervous system evaluation of patients with vasomotor rhinitis. Laryngo-scope 110:1828-1831, 2000.
 
5) Ishman SL, Martin TJ, Hambrook DW et al.:Autonomic nerves system evalua-tion in allergic rhinitis. Otolaryngol Head Neck Surg 136:51-56, 2007.
 
6) Kalogeronlitros D, Syrigou EK, Makris M et al.:Nasal provocation of patients with allergic rhinitis and the hypotha-lamic-pituitary-adrenal axis. Ann Allergy Asthma Immunol 98:269-273, 2007.
 
7) Kventnansky R, Hukuhara K, Pacak K et al.:Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immunobilization stress in rats. Endocrinology 133:1411-1419, 1993.
 
P.20 掲載の参考文献
1) 秀 道広・他:蕁麻疹・血管性浮腫の治療ガイドライン. 日皮会誌 115:703-715, 2005.
 
2) Chida Y et al.:The effects of psycho-logical intervention on atopic dermatitis. A systematic review and meta-analysis. Int Arch Allergy Immunol 144:1-9, 2007.
 
3) 古江増隆・他:アトピー性皮膚炎診療ガイドライン. 日皮会誌 119:1515-1534, 2009.
 
4) Okabe T et al.:The release of leukotri-ene B4 from human skin in response to substance P:evidence for the functional heterogeneity of human skin mast cells among individuals. Clin Exp Immunol 124:150-156, 2001.
 
5) Okabe T et al.:Substance P induces tumor necrosis factoralpha release from human skin via mitogen-activated protein kinase. Eur J Pharmacol 398:309-315, 2000.
PubMed
6) Takahagi S et al.:Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria asso-ciated with atopic diathesis. Br J Derma-tol 160:426-428, 2009.
 

REVIEW & TOPICS

P.26 掲載の参考文献
1) James AL, Wenzel S:Clinical relevance of airway remodelling in airway diseases. Eur Respir J 30:134-155, 2007.
PubMed
2) James AL, Pare PD, Hogg JC:The mechanics in airway narrowing in asthma. Am Rev Respir Dis 139:242-246, 1989.
PubMed
3) Niimi A, Matsumoto H, Minakuchi M et al.:Airway remodelling in cough-variant asthma. Lancet 356:564-565, 2000.
PubMed
4) Niimi A, Matsumoto H, Takemura M et al.:Clinical assessment of airway remodeling in asthma:utility of computed tomography. Clin Rev Allergy Immunol 27:45-57, 2004.
PubMed
5) 新実彰男, 小熊 毅:喘息におけるCT画像. 呼吸器科 14:337-384, 2008.
 
6) Niimi A, Matsumoto H, Amitani R et al.:Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices. Am J Respir Crit Care Med 162:1518-1523, 2000.
PubMed
7) Matsumoto H, Niimi A, Tabuena RP et al.:Airway wall thickening in patients with cough variant asthma and nonasthmatic chronic cough. Chest 131:1042-1049, 2007.
PubMed
8) Gono H, Fujimoto K, Kawakami S et al.:Evaluation of airway wall thickness and air trapping by HRCT in asymptolnatic asthma. Eur Respir J 22:965-971, 2003.
PubMed
9) Takemura M, Niimi A, Minakuchi M et al.:Bronchial dilatation in asthma. Relation to clinical and sputum indices. Chest 125:1352-1358, 2004.
PubMed
10) Niimi A, Matsumoto H, Amitani R et al.:Effect of short-term treatment with inhaled corticosteroid on airway wall thickening in asthma. Am J Med 116:725-731, 2004.
PubMed
11) Niimi A, Matsumoto H, Takemura M et al.:Relation of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med 168:983-988, 2003.
 
12) Matsumoto H, Niimi A, Takemura M et al.:Relationship of airway wall thickening to an imbalance between matrix metalloprote-inasc-9 and its inhibitor in asthma. Thorax 60:277-281, 2005.
 
13) Yamaguchi M, Niimi A, Matsumoto H et al.:Sputum levels of transforming growth factor-β1 in asthma:Relation to clinicoradiological findings. J Invest Allergol Clin Immunol 18:202-206, 2008.
 
14) Jongepier H, Boezen HM, Dijkstra A et al.:Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clin Exp Allergy 34:757-760, 2004.
PubMed
15) Ueda T. Niimi A. Matsumoto H et al.:TGFBI promoter polymor-phism C-509T and pathophysiology of asthma. J Allergy Clin Immunol 121:659-656, 2008.
 
16) Ueda T. Niimi A. Matsumoto M et al.:Role of small airways in asthma:investigation using high-resolution computed tomography. J Allergy Clin Immunol 118:1019-1025, 2006.
 
17) Hasegawa M, Nasuhara Y, Onodera Y et al.:Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173:1309-1315, 2006.
PubMed
18) Gupta S, Siddiqui, S, Haldar P et al.:Qualitative analysis of High Resolution Computed Tomography scans in severe asthma. Chest 136:1521-1528, 2009.
PubMed
P.30 掲載の参考文献
1) Brighton PJ, Szekeres PG, Willars GB:Neuromedin U and its receptors:structure, function, and physiological rolcs. Pharmacol Rev 56(2):231-248, 2004.
 
2) Budhiraja S, Chugh A, Neuromedin U:Physiology, pharmacol-ogy and therapeutic potential. Fundam Clin Pharmacol 23(2):149-157, 2009.
 
3) Mori K, Miyazato M, Ida T, Murakami N, Serino R et al.:Identi-fication of neuromedin S and its possible role in the mammalian circadian oscillator system. EMBO J 24(2):325-335, 2005.
 
4) Miyazato M, Mori K, Ida T, Kojima M, Murakami N, Kangawa K:Identification and functional analysis of a novel ligand for G protein-coupled receptor, Neuromedin S. Regul Pept 145(1～3):37-41, 2008.
 
5) Moriyama M, Sato T, Inoue H, Fukuyama S, Teranishi H et al.:The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells. J Exp Med 202(2):217-224, 2005.
PubMed
6) Minamino N, Kangawa K, Matsuo H:Neuromedin U-8 and U-25:novel uterus stimulating and hypertensive peptides identified in porcine spinal cord. Biochem Biophys Res Commun 130 (3):1078-1085, 1985.
PubMed
7) Fisher JM, Scheller RH:Prohormone processlng and the secretory pathway. J Biol Chem 263(32):16515-16518, 1988.
PubMed
8) Abbondanzo SJ, Manfra DJ, Chen SC, Pinzon-Ortiz M. Sun Y et al.:Nmurl-/-mice are not protected from cutaneous inflammation. Biochem Biophys Res Commun 378(4):777-782, 2009.
 
9) Karimi K, Redegeld FA, Heijdra B, Nijkamp FP:Stem cell fac-tor and Interleukin-4 induce murine bone marrow cells to develop into mast cells with connective tissue type characteristics in vitro. Exp Hematol 27(4):654-662, 1999.
 
P.34 掲載の参考文献
1) Rostom A, Dube C, Lewin G et al.:Nonsteroidal anti-inflamma-tory drugs and cyclooxygenase-2 inhibitors for prilnary preven-tion of colorectal cancer:a systemic review prepared for the US preventive Service Task Force. Ann Intern Med 146:376-389, 2007.
 
2) Matsuo M, Yonemitsu N, Zaitsu M et al.:Expression of prosta-glandin H synthasc-2 in human brain tumors. Acta Neuropathol 102:181-187, 2001.
 
3) Matsuo M, Yoshida N, Zaitsu M et al.:Inhibition of human glioma cell growth by a PHS-2 inhibitor, NS398, and a prosta-glandin E receptor subtype EP1-selective antagonist, SC51089. J Neuro-Oncol 66:285-292, 2004.
 
4) Zhang R, Li S:COX-2 as a novel target of CRF family pep-tides' participating in inflammation. Biochem Biophys Res Comm 382:483-485, 2009.
 
5) Wang D, DuBois RN:Prostaglandins and Cancer. Gut 55:115-122, 2006.
PubMed
6) Said SI, Mutt V:Polypeptide with broad biological activity:iso-lation from small intestine. Science 169:1217-1218, 1970.
 
7) Linder S, Barkhem T, Norberg A et al.:Structure and expression of the gene encoding the vasoactive intestinal peptide precursor. Proc Natl Acad Sci USA 84:605-609, 1987.
PubMed
8) Delgado M, Pozo D, Ganea D:The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev 56:249-290, 2004.
PubMed
9) Voice JK, Dorsam G, Lee H et al.:Allergic diathesis in trans-genic mice with constitutive T cell expression of inducible vasoac-tive intestinal peptide receptor. FASEB J 15:2489-2496, 2001.
 
10) Delgado M, Abad C, Martinez C et al.:Vasoactive Intestinal pep-tide prevents experimental arthritis by down-regulating both auto-immune and inflammatory components of the disease. Nat Med 7:563-568, 2001.
 
11) Gonzalez-Rey E Delgado M:Vasoactive intestinal peptide inhibits cyclooxygenase-2 expression in activated macroages, microglia, and dendric cells Brain. Behavior and Immunity 22:35-41, 2008.
 
12) Karin M, Greten FR:NF-kappaB:linking inflammation and immunity to cancer development and progression. Nat Rev Immu-nol 5:749-759, 2005.
 
13) Chorny A, Gonzalez-Rey E, Varela N et al.:Signaling mecha-nisms of vasoactive intestinal peptide in inflammatory conditions. Regul Pept 137:67-74, 2006.
 
14) Deng W-G, Zhu Y, Wu KK:Role of p300 and PCAF in regulat-ing cyclooxygenase-2 promoter activation by inflammatory mediators. Blood 103:2135-2142, 2004.
 
P.38 掲載の参考文献
1) 日本皮膚科学会アトピー性皮膚炎診療ガイドライン作成委員会 ; 古江増隆, 佐伯秀久, 古川福実・他:アトピー性皮膚炎診療ガイドライン. 日皮会誌 119:1515-1534, 2009.
 
2) Kawashima M, Tango T, Noguchi T et al.:Addition of fexofena-dine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, dou-ble-blind, placebo-controlled, parallel-group study. Br J Derma-tol 148:1212-1221, 2003.
 
3) 川島 眞, 原田昭太郎:抗アレルギー薬を併用した標準的薬物療法がアトピー性皮膚炎患者の痒みとQuality of Life (QOL)に及ぼす影響に関する調査. 臨床皮膚科 60:661-667, 2006.
 
4) Tominaga M, Tengara S, Kamo A et al.:Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis. J Dermatol Sci 55:40-46, 2009.
PubMed
5) Heyer G, Hornstein OP, Handwerker HO:Reactions to intradermally injected substance P and topically applied mustard oil in atopic dermatitis patients. Acta Derm Venereol 71:291-295, 1991.
PubMed
6) Andoh T, Nagasawa T, Satoh M et al.:Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice. J Pharmacol Exp Ther 286:1140-1145, 1998.
PubMed
7) Toyoda M, Nakamura M, Makino T et al.:Nerve growth factor and subtance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 147:71-79, 2002.
 
8) Hon KL, Lam MC, Wong KY et al.:Pathophysiology of noctur-nal scratching in childhood atopic dermatitis:the role of brain-derived neurotrophic factor and substance P. Br J Dermatol 157:922-925, 2007.
 
9) Tamura T, Amano T, Ohmori K et al.:The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice. Eur J Pharmacol 524:149-154, 2005.
PubMed
10) Matsubara M, Tamura T, Ohmori K et al.:Histamine H1 receptor antagonist blocks histamine-induced proinflammatory cytokine production through inhibition of Ca2+-dependent protein kinase C, Raf/MEK/ERK and IKK/IκB/NF-κB signal cascades. Biochem Pharmacol 69:433-449, 2005.
 
11) Tamura T, Matsubara M, Amano T et al.:Olopatadine ameliorates rat experimental cutaneous inflammation by improving skin barrier function. Pharmacology 81:118-126, 2008.
PubMed
12) Macfarlane SR, Seatter MJ, Kanke T et al.:Proteinase-activated receptor. Pharmacol Rev 53:363-400, 2001.
 
13) Steinhoff M, Corvera CU, Thoma MS et al.:Proteinase-activated receptor-2 in human skin:tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 8:282-294, 1999.
PubMed
14) Steinhoff M, Neisius U, Ikoma A et al.:Proteinase-activated receptor-2 mediates itch:a novel pathway for pruritus in human skin. J Neurosci 23:6176-6180, 2003.
PubMed
15) Yoshizaki A, Sato S:Olopatadine hydrochloride inhibits scratch-ing behavior induced by a proteinase-activated receptor 2 agonist in mice. J Dermatol Sci 56:136-139, 2009.
 
16) Peters EM, Ericson ME, Hosoi J et al.:Neuropeptide control mechanisms in cutaneous biology:physiological and clinical significance. J Invest Dermatol 126:1937-1947, 2006.
PubMed
17) 祥 宰, 清水和宏, 佐藤伸一:ストレスによって増強された皮膚炎に対するオロパタジン塩酸塩の抑制効果. 臨牀と研究 85:568-572, 2008.
Medical*Online
18) Hosokawa C, Takeuchi S, Furue M:Severity scores, itch scores and plasma substance P levels in atopic dermatitis treated with standard topical therapy with oral olopatadine hydrochloride. J Dermatol 36:185-190, 2009.
PubMed
19) Izu K, Tokura Y:The various effects of four H1-antagonists on serum substance P levels in patients with atopic dcrmatitis. J Der-matol 32:776-781, 2005.
 
20) 竹中 基, Bae Sang Jae, 佐藤伸一:アトピー性皮膚炎血漿中のサブスタンスPと末梢血単球での neural endopeptidase mRNAの発現の推移についての検討. 臨牀と研究 84:278-282, 2007.
Medical*Online

EDUCATIONAL LECTURE

P.45 掲載の参考文献
1) Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD et al.:The capsaicin receptor:a heat-activated ion channel in the pain pathway. Nature 389:816-824, 1997.
PubMed
2) Venkatachalam K, Montell C:TRP channels. Annual review of biochernistry 76:387-417, 2007.
 
3) Dhaka A, Viswanath V, Patapoutian A:Trp ion channels and temperature sensation. Annu Rev Neurosci 29:135-161, 2006.
PubMed
4) Talavera K, Nilius B, Voets T:Neuronal TRP channels:thermometers, pathfinders and life-savers. Trends Neurosci 31:287-295, 2008.
PubMed
5) Tominaga M, Caterina MJ:Thermosensation and pain. J Neurobiol 61:3-12, 2004.
 
6) Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H et al.:The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21:531-543, 1998.
PubMed
7) Sharif-Naeini R, Ciura S, Bourque CW:TRPV1 gene required for thermosensory transduction and anticipatory secretion from vasopressin neurons during hyperthermia. Neuron 58:179-185, 2008.
PubMed
8) Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J et al, :Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288:306-313, 2000.
PubMed
9) Chizh BA, O'Donnell MB, Napolitano A, Wang J, Brooke AC et al.:The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain 132:132-141, 2007.
 
10) Gavva NR, Treanor JJ, Garami A, Fang L, Surapaneni S et al.:Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain 136:200-210, 2008.
 
11) Shimosato G, Amaya F, Ueda M, Tanaka Y, Decosterd I et al.:Peripheral inflammation induces up-regulation of TRPV2 expression in rat DRG. Pain 119:225-232, 2005.
PubMed
12) Mandadi S, Sokabe T, Shibasaki K, Katanosaka K, Mizuno A et al.:TRPV3 in keratinocytes transmits temperature information to sensory neurons via ATP. Pflugers Arch 458:1093-1102, 2009.
PubMed
13) Moqrich A, Hwang SW, Earley TJ, Petrus MJ, Murray AN et al.:Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin. Science 307:1468-1472, 2005.
PubMed
14) Lee H, Iida T, Mizuno A, Suzuki M, Caterina MJ:Altered ther-mal selection behavior in mice lacking transient receptor potential vanilloid 4. J Neurosci 25:1304-1310, 2005.
 
15) Shibasaki K, Suzuki M, Mizuno A, Tominaga M:Effects of body temperature on neural activity in the hippocampus:regulation of resting membrane potentials by transient receptor potential vanilloid 4. J Neurosci 27:1566-1575, 2007.
PubMed
16) Bautista DM, Siemens J, Glazer JM, Tsuruda PR, Basbaum AI et al.:The menthol receptor TRPM8 is the principal detector of environmental cold. Nature 448:204-208, 2007.
PubMed
17) Colburn RW, Lubin ML, Stone DJ, Jr., Wang Y, Lawrence D et al.:Attenuated cold sensitivity in TRPM8 null mice. Neuron 54:379-386, 2007.
PubMed
18) Dhaka A, Murray AN, Mathur J, Earley TJ, Petrus MJ et al.:TRPM8 is required for cold sensation in mice. Neuron 54:371-378, 2007.
PubMed
19) Xing H, Chen M, Ling J, Tan W, Gu JG:TRPM8 mechanism of cold allodynia after chronic nerve injury. J Neurosci 27:13680-13690, 2007.
PubMed
20) Bautista DM, Jordt SE, Nikai T, Tsuruda PR, Read AJ et al.:TRPA1 mediates the lnflammatory actions of environmental irritants and proalgesic agents. Cell 124:1269-1282, 2006.
 
21) Kwan KY, Allchorne AJ, Vollrath MA, Christensen AP, Zhang DS et al.:TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction. Neuron 50:277-289, 2006.
 
22) Karashima Y, Talavera K, Everaerts W, Janssens A, Kwan KY et al.:TRPA1 acts as a cold sensor in vitro and in vivo. Proc Natl Acad Sci U S A 106:1273-1278, 2009.
PubMed
23) Fajardo O, Meseguer V, Belmonte C, Viana F:TRPA1 channels mediate cold temperature sensing in mammalian vagal sensory neurons:pharmacological and genetic evidence. J Neurosci 28:7863-7875, 2008.
PubMed
24) Obata K, Katsura H, Mizushima T, Yamanaka H, Kobayashi K et al.:TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury. J Clin Invest 115:2393-2401, 2005.
PubMed
25) Fujita F, Uchida K, Moriyama T, Shima A, Shibasaki K et al.:Intracellular alkalization causes pain sensation through activation of TRPA1 in mice. J Clin Invest 118:4049-4057, 2008.
PubMed
26) Hinman A, Chuang HH, Bautista DM, Julius D:TRP channel activation by reversible covalent modification. Proc Natl Acad Sci U S A 103:19564-19568, 2006.
PubMed
27) Macpherson LJ, Dubin AE, Evans MJ, Marr F, Schultz PG et al.:Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature 445:541-545, 2007.
PubMed
28) Zurborg S, Yurgionas B, Jira JA, Caspani O, Heppenstall PA:Direct activation of the ion channel TRPA1 by Ca2+. Nat Neurosci 10:277-279, 2007.
PubMed
29) Dai Y, Wang S, Tominaga M, Yamamoto S, Fukuoka T et al.:Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain. J Clin Invest 117:1979-1987, 2007.
 
30) Togashi K, Hara Y, Tominaga T, Higashi T, Konishi Y et al.:TRPM2 activation by cyclic ADP-ribose at body temperature is involved in insulin secretion. Embo J 25:1804-1815, 2006.
PubMed
31) Yamamoto S, Shimizu S, Kiyonaka S, Takahashi N, Wajima T et al.:TRPM2-mediated Ca2+ influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat Med 14:738-747, 2008.
PubMed
32) Gerzanich V, Woo SK, Vennekens R, Tsymbalyuk O, Ivanova S et al.:De novo expression of Trpm4 initiates secondary hemorrhage in spinal cord injury. Nat Med 15:185-191, 2009.
PubMed
33) Talavera K, Yasumatsu K, Vbets T, Droogmans G, Shigemura N et al.:Heat activation of TRPM5 underlies thennal sensitivity of sweet taste. Nature 438:1022-1025, 2005.
 

DRUG-REPORT

P.53 掲載の参考文献
1) Huang J, Zhang X, McNaughton PA:Modulation of temperature-sensitive TRP channels. Semin Cell Dev Biol 17:638-645, 2006.
PubMed
2) Tsavaler L, Shapero MH, Morkowski S, Laus R:Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res 61:3760-3769, 2001.
PubMed
3) McKemy DD, Neuhausser WM, Julius D:Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 416:52-58, 2002.
PubMed
4) Peier AM, Moqrich A, Hergarden AC, Reeve AJ, Andersson DA et al.:ATRP channel that senses cold stimuli and menthoL Cell 108:705-715, 2002.
 
5) Behrendt HJ, Germann T, Gillen C, Hatt H, Jostock R:Characterization of the mouse cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric imaging plate reader (FLIPR)assay. Br J Pharmacol 141:737-745, 2004.
PubMed
6) Beck B, Bidaux G, Bavencoffe A, Lemonnier L, Thebault S et aL:Prospects for prostate cancer imaging and therapy using high-affinity TRPM8 activators. Cell Calcium 41:285-294, 2007.
PubMed
7) Bromm B, Scharein E, Darsow U, Ring J:Effects of menthol and cold on histamine-induced itch and skin reactions in man. Neurosci Lett 187:157-160, 1995.
PubMed
8) Bavandi A, Meingassner JG, Becker S:Diet-induced dermatitis response of hairless rats to systemic treatment with cyclosporin A (Sandimmun), cyclosporin H and FK506. Exp Dematol 1:199-205, 1992.
 
9) Biro T, Ko MC, Bromm B, Wei ET, Bigliardib P et al:How best to fight that nasty itch-from new insights into the neuroimmunol logical, neuroendocrine, and neurophysiological bases of pruritusto novel therapeutic approaches. Exp Dermatol 14:225-240, 2005.
 
10) Mihara K, Kuratani K, Matsui T, Nakamura M, Ybkota K:Vital role of the itch-scratch response in development of spontaneous dermatitis in NC/Nga mice. Br J Dermatol 151:335-345, 2004.
PubMed
11) Dhaka A, Murray AN, Mathur J, Earley TJ, Petrus MJ, Patapoutian A:TRPM8 is required for cold sensation in mice. Neuron 54:371-378, 2007.
PubMed
12) Proudfoot CJ, Garry EM, Cottrell DF, Rosie R, Anderson H et al.:Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain. Curr Biol 16:1591-1605, 2006.
PubMed

書評

最近チェックした商品履歴

Loading...